Cohere Health vs Xsolis
The two most substantial utilization management platforms in this index, and they differ on whose side they stand. Cohere sells to health plans, covering utilization management, payment integrity, appeals, care management and policy work with one consistent model of medical necessity, and it holds accreditation that matters because a carrier stays responsible for compliance regardless of which vendor it used. Xsolis is the only vendor here positioned between payer and provider, scoring medical necessity continuously so both parties argue from the same number, with peer reviewed research behind that score and the strongest security posture in the cluster. The shared score is the more interesting idea, because most utilization disputes are arguments about evidence rather than about rules. Neither publishes a bias evaluation, in the one lane where the output can end in care denied.
- It is a clinical intelligence platform for the plan rather than a scoring engine, covering utilization management, payment integrity, appeals, care management and policy management under one model of medical necessity.
- Accreditation is held, which matters because a carrier is not exempt from prior authorization compliance because it used a vendor and the programme must meet a recognised standard.
- Breadth means one consistent determination logic across functions rather than several systems disagreeing about the same patient.
- It is the only vendor in this index sitting between payer and provider rather than serving one side, continuously scoring medical necessity so both parties argue from the same number.
- It is the only vendor in this cluster with peer reviewed research behind its score, published across multiple United States health systems.
- The security posture is the strongest here, with a risk based certification at the two year tier and a stated human in the loop design.
Side by Side
| Axis | C Cohere Health |
X Xsolis |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Utilization management is the part of this index where an AI output most directly results in care being delayed or denied, and neither vendor publishes a bias evaluation or subgroup performance analysis. The regulatory point is worth restating: a carrier remains responsible for prior authorization compliance regardless of vendor involvement, and at least one state requires the programme to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden. Ask both what proportion of AI informed adverse determinations are overturned on appeal, since that number describes calibration better than any accuracy claim.